Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-23
1994-06-14
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514331, 546201, 546233, A61K 31445, C07D21128, C07D40112
Patent
active
053210344
ABSTRACT:
Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
REFERENCES:
patent: 4122255 (1980-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4611054 (1986-09-01), Freidinger
patent: 4622331 (1986-11-01), Jozic
patent: 5030654 (1991-07-01), Barnish
patent: 5049548 (1991-09-01), Greenlee
patent: 5051405 (1991-09-01), Klein
Ruoslahti et al, "New Perspective in Cell Adhesion." Science 238 491-496 (1987).
Spatola et al, "Amide Bond Surrogate," Chem. Soc. J. Chem Communication 44(3) 821-833 (1988).
Duggan Mark E.
Hartman George D.
Ihle Nathan
Chang Celia
Ivy C. Warren
Matukaitis Paul
Merck & Co. , Inc.
Parr Richard S.
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249465